Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
An analysis of voucher advocacy: Taking a closer look at the uses and limitations of “gold standard” research

after school programs, family programs

Jameson T, Lubienski C.
GSID: l1pZo7NhFZAJ
C Lubienski, T Jameson Brewer - Peabody Journal of Education, 2016 - Taylor & Francis

Voucher proponents have increasingly pursued empirical evidence on the effectiveness of vouchers as a form of education improvement, in addition to advocating for vouchers on …

Cite
Lubienski, C., & Jameson Brewer, T. (2016). An analysis of voucher advocacy: Taking a closer look at the uses and limitations of “gold standard” research. Peabody Journal of Education, 91(4), 455-472.
Lubienski, Christopher, and T. Jameson Brewer. "An analysis of voucher advocacy: Taking a closer look at the uses and limitations of “gold standard” research." Peabody Journal of Education 91.4 (2016): 455-472.
Copy Download .nbib Format: MLA
Review of “A win-win solution” and “The participant effects of private school vouchers across the globe.”

after school programs, family programs

Lubienski C.
GSID: M-QbgY6TaHcJ
C Lubienski - Boulder, CO: National Education Policy Center, 2016 - scholar.colorado.edu

The degree to which students benefit from vouchers to attend private schools has been debated for years, with many studies suggesting little to modest benefits, at best, but also no …

Cite
Lubienski, C. (2016). Review of “A win-win solution” and “The participant effects of private school vouchers across the globe.”. Boulder, CO: National Education Policy Center.
Lubienski, Christopher. "Review of “A win-win solution” and “The participant effects of private school vouchers across the globe.”." Boulder, CO: National Education Policy Center (2016).
Copy Download .nbib Format: MLA
Intracranial gliofibroma: a case report and review of the literature.

Case reports in pathology

Gargano P, Zuccaro G, Lubieniecki F.
PMID: 25126436
Case Rep Pathol. 2014;2014:165025. doi: 10.1155/2014/165025. Epub 2014 Jul 13.

Gliofibroma is a rare tumor with biphasic morphology, commonly occurring in the first two decades of life. Currently, the tumor is not listed as a distinct entity in the current World Health Organization (WHO) classification of central nervous system...

Cite
Gargano P, Zuccaro G, Lubieniecki F. Intracranial gliofibroma: a case report and review of the literature. Case Rep Pathol. 2014;2014:165025doi: 10.1155/2014/165025.
Gargano, P., Zuccaro, G., & Lubieniecki, F. (2014). Intracranial gliofibroma: a case report and review of the literature. Case reports in pathology, 2014165025. https://doi.org/10.1155/2014/165025
Gargano, Patricia, et al. "Intracranial gliofibroma: a case report and review of the literature." Case reports in pathology vol. 2014 (2014): 165025. doi: https://doi.org/10.1155/2014/165025
Gargano P, Zuccaro G, Lubieniecki F. Intracranial gliofibroma: a case report and review of the literature. Case Rep Pathol. 2014;2014:165025. doi: 10.1155/2014/165025. Epub 2014 Jul 13. PMID: 25126436; PMCID: PMC4122050.
Copy Download .nbib Format: NLM
Aberrant O-glycosylation modulates aggressiveness in neuroblastoma.

Oncotarget

Cuello HA, Segatori VI, Albertó M, Gulino CA, Aschero R, Camarero S, Mutti LG, Madauss K, Alonso DF, Lubieniecki F, Gabri MR.
PMID: 30344930
Oncotarget. 2018 Sep 25;9(75):34176-34188. doi: 10.18632/oncotarget.26169. eCollection 2018 Sep 25.

Neuroblastoma (NB) is the most common pediatric malignancy diagnosed before the first birthday in which MYCN oncogene amplification is associated with poor prognosis. Although aberrant glycosylation is an important actor in cell biology, little is known about its role...

Cite
Cuello HA, Segatori VI, Albertó M, et al. Aberrant O-glycosylation modulates aggressiveness in neuroblastoma. Oncotarget. 2018;9(75):34176-34188doi: 10.18632/oncotarget.26169.
Cuello, H. A., Segatori, V. I., Albertó, M., Gulino, C. A., Aschero, R., Camarero, S., Mutti, L. G., Madauss, K., Alonso, D. F., Lubieniecki, F., & Gabri, M. R. (2018). Aberrant O-glycosylation modulates aggressiveness in neuroblastoma. Oncotarget, 9(75), 34176-34188. https://doi.org/10.18632/oncotarget.26169
Cuello, Hector A, et al. "Aberrant O-glycosylation modulates aggressiveness in neuroblastoma." Oncotarget vol. 9,75 (2018): 34176-34188. doi: https://doi.org/10.18632/oncotarget.26169
Cuello HA, Segatori VI, Albertó M, Gulino CA, Aschero R, Camarero S, Mutti LG, Madauss K, Alonso DF, Lubieniecki F, Gabri MR. Aberrant O-glycosylation modulates aggressiveness in neuroblastoma. Oncotarget. 2018 Sep 25;9(75):34176-34188. doi: 10.18632/oncotarget.26169. eCollection 2018 Sep 25. PMID: 30344930; PMCID: PMC6183345.
Copy Download .nbib Format: NLM
Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.

Hormone research in paediatrics

Vaiani E, Felizzia G, Lubieniecki F, Braier J, Belgorosky A.
PMID: 34167121
Horm Res Paediatr. 2021;94(1):9-17. doi: 10.1159/000517040. Epub 2021 Jun 24.

Langerhans cell histiocytosis (LCH) is a disorder of the mononuclear phagocyte system that can affect almost any organ and system. The most common central nervous system (CNS) manifestation in LCH is the infiltration of the hypothalamic-pituitary region leading to...

Cite
Vaiani E, Felizzia G, Lubieniecki F, et al. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System. Horm Res Paediatr. 2021;94(1):9-17doi: 10.1159/000517040.
Vaiani, E., Felizzia, G., Lubieniecki, F., Braier, J., & Belgorosky, A. (2021). Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System. Hormone research in paediatrics, 94(1), 9-17. https://doi.org/10.1159/000517040
Vaiani, Elisa, et al. "Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System." Hormone research in paediatrics vol. 94,1 (2021): 9-17. doi: https://doi.org/10.1159/000517040
Vaiani E, Felizzia G, Lubieniecki F, Braier J, Belgorosky A. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System. Horm Res Paediatr. 2021;94(1):9-17. doi: 10.1159/000517040. Epub 2021 Jun 24. PMID: 34167121.
Copy Download .nbib Format: NLM
The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation.

Cell adhesion & migration

Villanueva AA, Sanchez-Gomez P, Muñoz-Palma E, Puvogel S, Casas BS, Arriagada C, Peña-Villalobos I, Lois P, Ramírez Orellana M, Lubieniecki F, Casco Claro F, Gallegos I, García-Castro J, Torres VA, Palma V.
PMID: 33724150
Cell Adh Migr. 2021 Dec;15(1):58-73. doi: 10.1080/19336918.2021.1892397.

Neuroblastoma is a highly metastatic tumor that emerges from neural crest cell progenitors. Focal Adhesion Kinase (FAK) is a regulator of cell migration that binds to the receptor Neogenin-1 and is upregulated in neuroblastoma. Here, we show that Netrin-1...

Cite
Villanueva AA, Sanchez-Gomez P, Muñoz-Palma E, et al. The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation. Cell Adh Migr. 2021;15(1):58-73doi: 10.1080/19336918.2021.1892397.
Villanueva, A. A., Sanchez-Gomez, P., Muñoz-Palma, E., Puvogel, S., Casas, B. S., Arriagada, C., Peña-Villalobos, I., Lois, P., Ramírez Orellana, M., Lubieniecki, F., Casco Claro, F., Gallegos, I., García-Castro, J., Torres, V. A., & Palma, V. (2021). The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation. Cell adhesion & migration, 15(1), 58-73. https://doi.org/10.1080/19336918.2021.1892397
Villanueva, Andrea A, et al. "The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation." Cell adhesion & migration vol. 15,1 (2021): 58-73. doi: https://doi.org/10.1080/19336918.2021.1892397
Villanueva AA, Sanchez-Gomez P, Muñoz-Palma E, Puvogel S, Casas BS, Arriagada C, Peña-Villalobos I, Lois P, Ramírez Orellana M, Lubieniecki F, Casco Claro F, Gallegos I, García-Castro J, Torres VA, Palma V. The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation. Cell Adh Migr. 2021 Dec;15(1):58-73. doi: 10.1080/19336918.2021.1892397. PMID: 33724150; PMCID: PMC7971226.
Copy Download .nbib Format: NLM
Clinical, Genomic, and Pharmacological Study of .

Cancers

Zugbi S, Ganiewich D, Bhattacharyya A, Aschero R, Ottaviani D, Sampor C, Cafferata EG, Mena M, Sgroi M, Winter U, Lamas G, Suñol M, Daroqui M, Baialardo E, Salas B, Das A, Fandiño A, Francis JH, Lubieniecki F, Lavarino C, Garippa R, Podhajcer OL, Abramson DH, Radvanyi F, Chantada G, Llera AS, Schaiquevich P.
PMID: 32971811
Cancers (Basel). 2020 Sep 22;12(9). doi: 10.3390/cancers12092714.

An uncommon subgroup of unilateral retinoblastomas with highly aggressive histological features, lacking aberrations in

Cite
Zugbi S, Ganiewich D, Bhattacharyya A, et al. Clinical, Genomic, and Pharmacological Study of . Cancers (Basel). 2020;12(9)doi: 10.3390/cancers12092714.
Zugbi, S., Ganiewich, D., Bhattacharyya, A., Aschero, R., Ottaviani, D., Sampor, C., Cafferata, E. G., Mena, M., Sgroi, M., Winter, U., Lamas, G., Suñol, M., Daroqui, M., Baialardo, E., Salas, B., Das, A., Fandiño, A., Francis, J. H., Lubieniecki, F., Lavarino, C., Garippa, R., Podhajcer, O. L., Abramson, D. H., Radvanyi, F., Chantada, G., Llera, A. S., & Schaiquevich, P. (2020). Clinical, Genomic, and Pharmacological Study of . Cancers, 12(9), . https://doi.org/10.3390/cancers12092714
Zugbi, Santiago, et al. "Clinical, Genomic, and Pharmacological Study of ." Cancers vol. 12,9 (2020). doi: https://doi.org/10.3390/cancers12092714
Zugbi S, Ganiewich D, Bhattacharyya A, Aschero R, Ottaviani D, Sampor C, Cafferata EG, Mena M, Sgroi M, Winter U, Lamas G, Suñol M, Daroqui M, Baialardo E, Salas B, Das A, Fandiño A, Francis JH, Lubieniecki F, Lavarino C, Garippa R, Podhajcer OL, Abramson DH, Radvanyi F, Chantada G, Llera AS, Schaiquevich P. Clinical, Genomic, and Pharmacological Study of . Cancers (Basel). 2020 Sep 22;12(9). doi: 10.3390/cancers12092714. PMID: 32971811; PMCID: PMC7565107.
Copy Download .nbib Format: NLM
Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma.

Journal of neuro-oncology

Baroni LV, Freytes C, Fernández Ponce N, Oller A, Pinto N, Gonzalez A, Maldonado FR, Sampor C, Rugilo C, Lubieniecki F, Alderete D.
PMID: 34505229
J Neurooncol. 2021 Oct;155(1):53-61. doi: 10.1007/s11060-021-03842-3. Epub 2021 Sep 09.

BACKGROUND: Many studies have demonstrated in the last years that once medulloblastoma has recurred, the probability of regaining tumor control is poor despite salvage therapy. Although re-irradiation has an emerging role in other relapsed brain tumors, there is a...

Cite
Baroni LV, Freytes C, Fernández Ponce N, et al. Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma. J Neurooncol. 2021;155(1):53-61doi: 10.1007/s11060-021-03842-3.
Baroni, L. V., Freytes, C., Fernández Ponce, N., Oller, A., Pinto, N., Gonzalez, A., Maldonado, F. R., Sampor, C., Rugilo, C., Lubieniecki, F., & Alderete, D. (2021). Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma. Journal of neuro-oncology, 155(1), 53-61. https://doi.org/10.1007/s11060-021-03842-3
Baroni, Lorena V, et al. "Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma." Journal of neuro-oncology vol. 155,1 (2021): 53-61. doi: https://doi.org/10.1007/s11060-021-03842-3
Baroni LV, Freytes C, Fernández Ponce N, Oller A, Pinto N, Gonzalez A, Maldonado FR, Sampor C, Rugilo C, Lubieniecki F, Alderete D. Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma. J Neurooncol. 2021 Oct;155(1):53-61. doi: 10.1007/s11060-021-03842-3. Epub 2021 Sep 09. PMID: 34505229.
Copy Download .nbib Format: NLM
Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma.

Cancers

Aschero R, Francis JH, Ganiewich D, Gomez-Gonzalez S, Sampor C, Zugbi S, Ottaviani D, Lemelle L, Mena M, Winter U, Correa Llano G, Lamas G, Lubieniecki F, Szijan I, Mora J, Podhajcer O, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lavarino C, Chantada GL.
PMID: 33567541
Cancers (Basel). 2021 Feb 08;13(4). doi: 10.3390/cancers13040673.

Most reports about copy number alterations (CNA) in retinoblastoma relate to patients with intraocular disease and features of children with extraocular relapse remain unknown, so we aimed to describe the CNA in this population. We evaluated 23 patients and...

Cite
Aschero R, Francis JH, Ganiewich D, et al. Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma. Cancers (Basel). 2021;13(4)doi: 10.3390/cancers13040673.
Aschero, R., Francis, J. H., Ganiewich, D., Gomez-Gonzalez, S., Sampor, C., Zugbi, S., Ottaviani, D., Lemelle, L., Mena, M., Winter, U., Correa Llano, G., Lamas, G., Lubieniecki, F., Szijan, I., Mora, J., Podhajcer, O., Doz, F., Radvanyi, F., Abramson, D. H., Llera, A. S., Schaiquevich, P. S., Lavarino, C., & Chantada, G. L. (2021). Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma. Cancers, 13(4), . https://doi.org/10.3390/cancers13040673
Aschero, Rosario, et al. "Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma." Cancers vol. 13,4 (2021). doi: https://doi.org/10.3390/cancers13040673
Aschero R, Francis JH, Ganiewich D, Gomez-Gonzalez S, Sampor C, Zugbi S, Ottaviani D, Lemelle L, Mena M, Winter U, Correa Llano G, Lamas G, Lubieniecki F, Szijan I, Mora J, Podhajcer O, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lavarino C, Chantada GL. Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma. Cancers (Basel). 2021 Feb 08;13(4). doi: 10.3390/cancers13040673. PMID: 33567541; PMCID: PMC7915502.
Copy Download .nbib Format: NLM
Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients.

Molecular genetics and metabolism reports

Loos MA, Gomez G, Mayorga L, Caraballo RH, Eiroa HD, Obregon MG, Rugilo C, Lubieniecki F, Taratuto AL, Saccoliti M, Alonso CN, Aráoz HV.
PMID: 33717984
Mol Genet Metab Rep. 2021 Feb 25;27:100733. doi: 10.1016/j.ymgmr.2021.100733. eCollection 2021 Jun.

OBJECTIVE: To describe the clinical and molecular features of a group of Argentinian pediatric patients with mitochondrial DNA (mtDNA) disorders, and to evaluate the results of the implementation of a classical approach for the molecular diagnosis of mitochondrial diseases.METHODS:...

Cite
Loos MA, Gomez G, Mayorga L, et al. Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients. Mol Genet Metab Rep. 2021;27:100733doi: 10.1016/j.ymgmr.2021.100733.
Loos, M. A., Gomez, G., Mayorga, L., Caraballo, R. H., Eiroa, H. D., Obregon, M. G., Rugilo, C., Lubieniecki, F., Taratuto, A. L., Saccoliti, M., Alonso, C. N., & Aráoz, H. V. (2021). Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients. Molecular genetics and metabolism reports, 27100733. https://doi.org/10.1016/j.ymgmr.2021.100733
Loos, Mariana Amina, et al. "Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients." Molecular genetics and metabolism reports vol. 27 (2021): 100733. doi: https://doi.org/10.1016/j.ymgmr.2021.100733
Loos MA, Gomez G, Mayorga L, Caraballo RH, Eiroa HD, Obregon MG, Rugilo C, Lubieniecki F, Taratuto AL, Saccoliti M, Alonso CN, Aráoz HV. Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients. Mol Genet Metab Rep. 2021 Feb 25;27:100733. doi: 10.1016/j.ymgmr.2021.100733. eCollection 2021 Jun. PMID: 33717984; PMCID: PMC7933530.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries